Mitochondrial amyloid-β levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice

Journal of Alzheimer's Disease

Volumn 20, Issue SUPPL.2, 2010, Pages

  Dragicevic, Natasa ^a   Mamcarz, Malgorzata ^a   Zhu, Yuyan ^b   Buzzeo, Robert ^a   Tan, Jun ^b   Arendash, Gary W ^a,c   Bradshaw, Patrick C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; amygdala; cognitive function; cytochrome oxidase; membrane potential; mitochondrial; reactive oxygen species; respiration; striatum; synapse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYTOCHROME C OXIDASE; N,N,N',N' TETRAMETHYL 1,4 PHENYLENEDIAMINE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; BRAIN REGION; BREATHING RATE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HUMAN; MENTAL TASK; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RESPIRATION CONTROL; TRANSGENIC MOUSE; WORKING MEMORY;

EID: 77956197971     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100342     Document Type: Article

References (89)

1. Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuro-molecular Med 2, 215-231.
2. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
3. Bertoni-Freddari C, Fattoretti P, Casoli T, Meier-Ruge W, Ul-rich J (1990) Morphological adaptive response ofthe synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res 517, 69-75.
4. Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78, 151-164.
5. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann Neurol 27, 457-464.
6. Samuel W, Masliah E, Hill LR, Butters N, Terry R (1994) Hip-pocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44, 2081-2088.
7. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
8. Palay SL (1956) Synapses in the central nervous system. J Biophys Biochem Cytol 2, 193-202.
9. David G, Barrett EF (2000) Stimulation-evoked increases in cytosolic [Ca(2+)] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent. J Neurosci 20, 7290-7296.
10. Hartmann T (1999) Intracellular biology of Alzheimer's disease amyloid beta peptide. Eur Arch Psychiatry Clin Neurosci 249, 291-298.
11. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) Aggregation-related toxicity ofsynthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol 207, 367-368.
12. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's A beta peptide induces neurode-generation and apoptotic cell death in transgenic mice. Nat Genet 9, 21-30.
13. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90, 7951-7955.
14. Mattson MP, Partin J, Begley JG (1998) Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 807, 167-176.
15. Beal MF (1998) Mitochondrial dysfunction in neurodegener-ative diseases. Biochim Biophys Acta 1366, 211-223.
16. Offen D, Elkon H, Melamed E (2000) Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm Suppl, 153-166.
17. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49,618-632.
18. Lin MT, Beal MF (2006) Mitochondrial dysfunction and ox-idative stress in neurodegenerative diseases. Nature 443, 787795.
19. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21, 455-462.
20. Parker WD, Jr. (1991) Cytochrome oxidase deficiency in Alzheimer's disease. Ann N Y Acad Sci 640, 59-64.
21. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA (2002) Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80, 91-100.
22. Parks JK, Smith TS, Trimmer PA, Bennett JP, Jr., Parker WD, Jr. (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mi-tochondrial permeability transition in vitro. J Neurochem 76, 1050-1056.
23. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58, 495-505.
24. Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley RW, Huang Y (2005) Lipid-and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochon-drial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A 102, 18694-18699.
25. David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, Ravid R, Drose S, Brandt U, Muller WE, Eckert A, Gotz J (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 280, 23802-23814.
26. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, Gotz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 106, 20057-20062.
27. Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, Trounce IA(2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 25, 672-679.
28. Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, Takahashi RH, Carlson GA, Flint Beal M, Lin MT, Gouras GK (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 89, 13081312.
29. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, 2212-2215.
30. Sirk D, Zhu Z, Wadia JS, Shulyakova N, Phan N, Fong J, Mills LR (2007) Chronic exposure to sub-lethal beta-amyloid (Abeta) inhibits the import of nuclear-encoded proteins to mitochondria in differentiated PC12 cells. J Neurochem 103, 1989-2003.
31. Mungarro-Menchaca X, Ferrera P, Moran J, Arias C (2002) beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J Neurosci Res 68, 89-96.
32. Gillardon F, Rist W, Kussmaul L, Vogel J, Berg M, Danzer K, Kraut N, Hengerer B (2007) Proteomic and functional alter-ations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 7, 605-616.
33. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anan-datheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26, 9057-9068.
34. Eckert A, Hauptmann S, Scherping I, Rhein V, Muller-Spahn F, Gotz J, Muller WE (2008) Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis 5, 157-159.
35. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
36. Brown MR, Geddes JW, Sullivan PG (2004) Brain region-specific, age-related, alterations in mitochondrial responses to elevated calcium. JBioenerg Biomembr 36, 401-406.
37. Dunkley PR, Jarvie PE, Robinson PJ (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Pro-toc 3, 1718-1728.
38. Chandrasekaran K, Hazelton JL, Wang Y, Fiskum G, Kristian T (2006) Neuron-specific conditional expression of a mito-chondrially targeted fluorescent protein in mice. J Neurosci 26, 13123-13127.
39. Loewenstein DA, Acevedo A, Luis C, Crum T, Barker WW, Duara R (2004) Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia. J Int Neuropsychol Soc 10, 91-100.
40. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, Ankarcrona M (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U SA 105, 13145-13150.
41. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue L-F, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H (2004) ABAD Directly Links A{beta} to Mitochondrial Toxicity in Alzheimer's Disease. Science 304, 448-452.
42. Falkevall A, Alikhani N, Bhushan S, Pavlov PF, Busch K, Johnson KA, Eneqvist T, Tjernberg L, Ankarcrona M, Glaser E (2006) Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 281, 2909629104.
43. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG (2003) Mitochondrial targeting and a novel transmem-brane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161, 4154.
44. Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L (1997) Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A 94, 1550-1555.
45. Hebert SS, Serneels L, Dejaegere T, Horre K, Dabrowski M, Baert V, Annaert W, Hartmann D, Schmechel D.E.trooper B (2004) Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis 17, 260-272.
46. Siman R, Salidas S (2004) Gamma-secretase subunit composition and distribution in the presenilin wild-type and mutant mouse brain. Neuroscience 129, 615-628.
47. Bodendorf U, Danner S, Fischer F, Stefani M, Sturchler-Pierrat C, Wiederhold KH, Staufenbiel M, Paganetti P (2002) Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. J Neurochem 80, 799-806.
48. Irizarry MC, Locascio JJ, Hyman BT (2001) beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. Am J Pathol 158, 173-177.
49. Zohar O, Cavallaro S, D'Agata V, Alkon DL (2003) Quantification and distribution of beta-secretase alternative splice variants in the rat and human brain. Brain Res Mol Brain Res 115, 63-68.
50. Karkkainen I, Rybnikova E, Pelto-Huikko M, Huovila AP (2000) Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 15, 547-560.
51. Shinall H, Song ES, Hersh LB (2005) Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 44, 1534515350.
52. Lalonde R, Joyal CC, Beaudin S (1997) Effects of sodium azide on motor activity, motor coordination, and learning. Pharmacol Biochem Behav 56, 67-71.
53. Bennett MC, Rose GM (1992) Chronic sodium azide treatment impairs learning of the Morris water maze task. Behav Neural Biol 58, 72-75.
54. Luques L, Shoham S, Weinstock M (2007) Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil. Exp Neurol 206, 209-219.
55. Lombes A, Nakase H, Tritschler HJ, Kadenbach B, Bonilla E, DeVivo DC, Schon EA, DiMauro S (1991) Biochemical and molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Neurology 41, 491-498.
56. Bertoni-Freddari C, Fattoretti P, Casoli T, Di Stefano G, Gior-getti B, Balietti M (2008) Brain aging: The zinc connection. Exp Gerontol 43, 389-393.
57. Dhar SS, Wong-Riley MT (2009) Coupling of energy metabolism and synaptic transmission at the transcriptional level: role of nuclear respiratory factor 1 in regulating both cytochrome c oxidase and NMDA glutamate receptor subunit genes. J Neurosci 29, 483-492.
58. Brown MR, Sullivan PG, Geddes JW (2006) Synaptic mitochondria are more susceptible to Ca2+ overload than nonsy-naptic mitochondria. J Biol Chem 281, 11658-11668.
59. Naga KK, Sullivan PG, Geddes JW (2007) High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J Neurosci 27, 7469-7475.
60. Kann O, Kovacs R (2007) Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292, C641-C657.
61. Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev 80, 315-360.
62. Hollenbeck PJ (1996) The pattern and mechanism of mito-chondrial transport in axons. Front Biosci 1, d91-d102.
63. Bloom GS, Richards BW, Leopold PL, Ritchey DM, Brady ST (1993) GTP gamma S inhibits organelle transport along axonal microtubules. J Cell Biol 120, 467-476.
64. Chang DT, Reynolds IJ (2006) Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol 80, 241-268.
65. Cai Q, Sheng ZH (2009) Mitochondrial transport and docking in axons. Exp Neurol 218, 257-267.
66. Iijima-Ando K, Hearn SA, Shenton C, Gatt A, Zhao L, Iijima K (2009) Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 4, e8310.
67. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation ofmitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105, 19318-19323.
68. Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091.
69. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, At-wood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shi-mohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Pe-tersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21, 3017-3023.
70. Baloyannis SJ (2006) Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9, 119-126.
71. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lip-ton SA (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105.
72. Zhao XL, Wang WA, Tan JX, Huang JK, Zhang X, Zhang BZ, Wang YH, YangCheng HY, Zhu HL, Sun XJ, Huang FD (2010) Expression ofbeta-amyloid Induced age-dependent presynaptic and axonal changes in Drosophila. J Neurosci 30, 1512-1522.
73. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160, 189-200.
74. Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, Otera H, Nakanishi Y, Nonaka I, Goto Y, Taguchi N, Mori-naga H, Maeda M, Takayanagi R, Yokota S, Mihara K (2009) Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 11, 958-966.
75. Chen H, McCaffery JM, Chan DC (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548-562.
76. Nguyen PV, Marin L, Atwood HL (1997) Synaptic physiology and mitochondrial function in crayfish tonic and phasic motor neurons. J Neurophysiol 78, 281-294.
77. Billups B, Forsythe ID (2002) Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J Neurosci 22, 5840-5847.
78. David G, Barrett EF (2003) Mitochondrial Ca2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. J Physiol 548, 425-438.
79. Talbot JD, David G, Barrett EF (2003) Inhibition of mitochondrial Ca2+ uptake affects phasic release from motor terminals differently depending on external [Ca2+]. J Neurophysiol 90, 491-502.
80. Tang Y, Zucker RS (1997) Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 18, 483491.
81. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887.
82. Braak H, Braak E, Kalus P (1989) Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neu-ropathol 77, 494-506.
83. Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Nagren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO (2008) PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain 131, 1845-1853.
84. Love S, Wilcock GK, Matthews SM (1996) No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta Neuropathol 91, 432-436.
85. Suenaga T, Hirano A, Llena JF, Yen SH, Dickson DW (1990) Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease. Acta Neu-ropathol 80, 280-286.
86. Brustovetsky N, Brustovetsky T, Purl KJ, Capano M, Cromp-ton M, Dubinsky JM (2003) Increased susceptibility of stri-atal mitochondria to calcium-induced permeability transition. J Neurosci 23, 4858-4867.
87. Nishino H, Hida H, Kumazaki M, Shimano Y, Nakajima K, Shimizu H, Ooiwa T, Baba H (2000) The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 17, 251-260.
88. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mito-chondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
89. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD (2005) Mitochon-drial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19, 2040-2041.